跳至主導覽 跳至搜尋 跳過主要內容

Association between carotid-femoral pulse wave velocity and cardiovascular disease in individuals with moderate blood pressure: a systematic review and individual participant meta-analysis

  • Holly Pavey*
  • , Angela Wood
  • , Carmel M. Mceniery
  • , Majd AlGhatrif
  • , Banafsheh Arshi
  • , Eric Brunner
  • , Chen Huan Chen
  • , Hao Min Cheng
  • , Tine W. Hansen
  • , M. Kamram Ikram
  • , Maryam Kavousi
  • , Diana Kuh
  • , Allison L. Kuipers
  • , Edward G. Lakatta
  • , Allan Linneberg
  • , Francesco Mattace Raso
  • , Gary F. Mitchell
  • , João Maldonado
  • , Anne B. Newman
  • , Telmo Pereira
  • Kaisa Maki-Petaja, Martin Shipley, Ramachandran S. Vasan, Andrew Wong, Yoav Ben-Shlomo, Ian B. Wilkinson
*此作品的通信作者

研究成果同行評審

1 引文 斯高帕斯(Scopus)

摘要

Objectives The predictive value of carotid-femoral pulse wave velocity (cfPWV) for cardiovascular (CV) events in individuals with blood pressure (BP) 120–159/80–99 mm Hg, where more accurate risk stratification has the greatest clinical effect, is unknown. This study aims to determine whether cfPWV improves the prediction of CV events beyond traditional risk factors in individuals with moderate BP. Design A systematic review and meta-analysis. Data sources PubMed and EMBASE were searched through April 2023. Eligibility criteria We included prospective, population-based cohort studies with ≥1year follow-up that directly measured cfPWV as an index of arterial stiffness and reported incident CV disease (CVD), atherosclerotic CVD (ASCVD), coronary heart disease, stroke or all-cause mortality outcomes. Data extraction and synthesis Individual participant data from 11 cohorts (n=15987) were harmonised and analysed using two-stage random-effects meta-analysis. Incremental predictive and clinical utility analyses compared 10-year risk models with and without cfPWV. Results There were 1279 first atherosclerotic CV events over a median follow-up of 9.9 years. A 1-SD increase in loge(cfPWV) was associated with a 1.21-fold (95% CI 1.08 to 1.36) increase in risk of ASCVD. Adding cfPWV to traditional risk factors improved ASCVD prediction: change in discrimination (C-index): 0.0048 (95% CI 0.0002 to 0.0094), p=0.041. In hypothetical populations of 100000 individuals with moderate BP, cfPWV-guided treatment could reduce event rates by 2.7% and 3.1% under European and US guidelines, respectively. Conclusions Adding cfPWV to traditional CV risk factors may improve the prediction and classification of first CV events in individuals with moderate BP. Additional screening with cfPWV could enhance risk stratification for antihypertensive treatment initiations.

原文English
文章編號e101368
期刊BMJ Open
15
發行號12
DOIs
出版狀態Published - 15 12月 2025

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG 3 - 良好的健康和福祉
    SDG 3 良好的健康和福祉

指紋

深入研究「Association between carotid-femoral pulse wave velocity and cardiovascular disease in individuals with moderate blood pressure: a systematic review and individual participant meta-analysis」主題。共同形成了獨特的指紋。

引用此